Inflammatory Bowel Disease and Gut Microbiota: Current Strategies and Future Prospects in Nanomedicine (Hardcover)

1. Introduction to Gut Microbiota and Inflammatory Bowel Disease: A Systematic Review 2. Pathogenesis of Gut Microbiota in Inflammatory Bowel Disease (IBD) 3. Impact of Nutraceuticals on Gut Microbiota for the Management of IBD 4. Targeting Gut Microbiota with a Novel Drug Delivery System to Treat Inflammatory Bowel Disease (IBD) 5. Management of Gut Microbiota-Derived Bacterial Metabolites-Induced IBD 6. Correlation Between Host Genetics and Gut Microbiota in (IBD) 7. Oral siRNA-Based Nanomedicine for the Treatment of IBD 8. Site-Specific Targeted Novel Drug Delivery System for the Management of IBD 9. Surface-Modified Lipid Nanoparticle-Mediated Site-Specific Drug Delivery for IBD 10. Interplay Between Autophagy, Gut Microbiota, and IBD 11. Role of Reactive Oxygen Species (ROSs), Superoxide Dismutases (SODs), and Inflammation in Association with Gut Microbiota and IBD 12. Composition of Gut Microbiota Dysbiosis and Functional Food to Treat Inflammatory Bowel Disease (IBD) 13. Age-Related Gut Dysbiosis and Its Impact on IBD 14. Impact of Diseased Condition on Gut Microbiota in IBD 15. Role of Probiotics and Prebiotics in IBD 16. Application of Natural Products in Targeting Gut Microbiota for IBD Management 17. Future Prospects and Patents of Nanomedicines in Treating Inflammatory Bowel Disease